273 related articles for article (PubMed ID: 36262189)
1. Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement.
Ren Y; Nie L; Zhu S; Zhang X
Int J Nanomedicine; 2022; 17():4861-4877. PubMed ID: 36262189
[TBL] [Abstract][Full Text] [Related]
2. Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications.
Alenzi AM; Albalawi SA; Alghamdi SG; Albalawi RF; Albalawi HS; Qushawy M
Recent Pat Nanotechnol; 2023; 17(1):18-32. PubMed ID: 35227188
[TBL] [Abstract][Full Text] [Related]
3. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
[TBL] [Abstract][Full Text] [Related]
4. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation.
Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876
[TBL] [Abstract][Full Text] [Related]
5. A Compendium of Bioavailability Enhancement
Sharma S; Kumari N; Garg D; Chauhan S
Pharm Nanotechnol; 2023; 11(4):324-338. PubMed ID: 36892113
[TBL] [Abstract][Full Text] [Related]
6. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
[TBL] [Abstract][Full Text] [Related]
7. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
8. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.
Ullah S; Shah MR; Shoaib M; Imran M; Elhissi AM; Ahmad F; Ali I; Shah SW
Drug Deliv; 2016 Nov; 23(9):3480-3491. PubMed ID: 27247018
[TBL] [Abstract][Full Text] [Related]
9. The crossroad of nanovesicles and oral delivery of insulin.
Fadaei MR; Mohammadi M; Fadaei MS; Jaafari MR
Expert Opin Drug Deliv; 2023; 20(10):1387-1413. PubMed ID: 37791986
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of biocompatible triazole based non-ionic surfactant and its vesicular drug delivery investigation.
Imkan ; Ali I; Ullah S; Imran M; Saifullah S; Hussain K; Kanwal T; Nisar J; Raza Shah M
Chem Phys Lipids; 2020 May; 228():104894. PubMed ID: 32126217
[TBL] [Abstract][Full Text] [Related]
11. Self-emulsifying Drug Delivery System Improve Oral Bioavailability: Role of Excipients and Physico-chemical Characterization.
Zhu Y; Ye J; Zhang Q
Pharm Nanotechnol; 2020; 8(4):290-301. PubMed ID: 32781978
[TBL] [Abstract][Full Text] [Related]
12. Formulation Development and Evaluation of Novel Vesicular Carrier for Enhancement of Bioavailability of Poorly Soluble Drug.
Sharma S; Bhatt S; Saini V
Pharm Nanotechnol; 2021; 9(1):70-82. PubMed ID: 33231151
[TBL] [Abstract][Full Text] [Related]
13. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
Cherniakov I; Domb AJ; Hoffman A
Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
[TBL] [Abstract][Full Text] [Related]
14. Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers.
Jebastin K; Narayanasamy D
J Liposome Res; 2023 Mar; 33(1):1-33. PubMed ID: 35543241
[TBL] [Abstract][Full Text] [Related]
15. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
16. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
17. Recent Advancement of Polymersomes as Drug Delivery Carrier.
Singh K; Biharee A; Vyas A; Thareja S; Jain AK
Curr Pharm Des; 2022; 28(20):1621-1631. PubMed ID: 35418282
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
Kamboj S; Saini V; Bala S
ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.
Yaghoobian M; Haeri A; Bolourchian N; Shahhosseni S; Dadashzadeh S
Int J Nanomedicine; 2020; 15():8767-8781. PubMed ID: 33204087
[TBL] [Abstract][Full Text] [Related]
20. Composite alkali polysaccharide supramolecular nanovesicles improve biocharacteristics and anti-lung cancer activity of natural phenolic drugs via oral administration.
Huang Y; Hu X; Zhao H; He D; Li Y; Yang M; Yu Z; Li K; Zhang J
Int J Pharm; 2020 Jan; 573():118864. PubMed ID: 31765782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
